June 2019 Trans-Divisional Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year 2021 Concepts

NIAID Career Transition Award

Program Announcement With Special Receipt, Referral, and/or Review Considerations—proposed FY 2021 initiative

Contact: Shawn Gaillard

Objective: The purpose of the NIAID Career Transition Award (CTA) program is to

  • Increase and maintain a strong cohort of new and talented NIH-supported independent investigators who will address the health needs of the nation.

  • Facilitate the transition from a postdoctoral research position to an independent research position.

  • Assist postdoctoral fellows' transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist.

Description: The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the nation's biomedical, behavioral, and clinical research needs. In addition to this opportunity, NIH institutes and centers support a variety of other mentored career development programs designed to foster the transition of new investigators to research independence. These other programs may be more suitable for particular candidates who need a different kind of transition support. NIH also supports non-mentored career development programs for independent investigators. More information about career programs may be found on the NIH Extramural Training Mechanisms website.

NIAID Investigator-Initiated Program Project Applications

Program Announcement With Special Receipt, Referral, and/or Review Considerations—proposed FY 2021 initiative

Contacts:

DAIDSMartin Gutierrez

DAITCheryl Lapham

DMIDKaren Lacourciere

Objective: This funding opportunity announcement (FOA) invites investigator-initiated program project (P01) applications.

Description: The proposed program may address scientific areas relevant to NIAID’s mission, including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases. Each P01 application submitted in response to this FOA must include at least two related research projects that share a common central theme, focus, and/or overall objective.

NIAID Resource-Related Research Projects

Program Announcement With Special Receipt, Referral, and/or Review Considerations—proposed FY 2021 initiative

Contacts:

DAIDSMartin Gutierrez

DAITJoseph Breen

DMIDMaureen Beanan

Objective: This funding opportunity announcement invites investigator-initiated resource-related research project (R24) applications.

Description: The proposed resource must provide a significant benefit to currently funded high-priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to NIAID’s broader scientific community. It is anticipated that the request for resource support through the R24 activity code will occur on an infrequent basis and only in circumstances where other mechanisms of support from NIAID are not appropriate.

The proposed resources should be relevant to the scientific areas of NIAID’s mission, including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases.

Content last reviewed on